Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cottam

Showing results (501-510 of 563) with videos related to

Pageof 57
Sort By:
Journal of Medicinal Chemistry|October 12, 2019
Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune StimuliMichael Chan, Fitzgerald S Lao, Paul J Chu, et al.
Plos One|November 15, 2017
STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Journal of Medicinal Chemistry|October 20, 2017
Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 LigandsMichael Chan, Yuhei Kakitsubata, Tomoko Hayashi, et al.
Plos One|February 16, 2018
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Bioorganic & Medicinal Chemistry|July 18, 2021
Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activationNikunj M Shukla, Michael Chan, Fitzgerald S Lao, et al.
Antiviral Research|April 20, 2006
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard, Craig W Day, Kevin Bailey, et al.
The European Journal of Neuroscience|December 1, 2022
Medio-dorsal thalamic dysconnectivity in chronic knee pain: A possible mechanism for negative affect and pain comorbiditySarina J Iwabuchi, Marianne M Drabek, William J Cottam, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligandsAfshin Nour, Tomoko Hayashi, Michael Chan, et al.
Oncotarget|September 8, 2016
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapyMarka R Crittenden, Jason Baird, David Friedman, et al.
Cancer Research|July 19, 2002
Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of actionEmmanuel A Ojo-Amaize, Emeka J Nchekwube, Howard B Cottam, et al.
Pageof 57

Showing results (501-510 of 563) with videos related to

Sort By:
Pageof 57
Journal of Medicinal Chemistry|October 12, 2019
Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune StimuliMichael Chan, Fitzgerald S Lao, Paul J Chu, et al.
Plos One|November 15, 2017
STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Journal of Medicinal Chemistry|October 20, 2017
Structure-Activity Relationship Studies of Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 LigandsMichael Chan, Yuhei Kakitsubata, Tomoko Hayashi, et al.
Plos One|February 16, 2018
Correction: STING expression and response to treatment with STING ligands in premalignant and malignant diseaseJason R Baird, Zipei Feng, Hong D Xiao, et al.
Bioorganic & Medicinal Chemistry|July 18, 2021
Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activationNikunj M Shukla, Michael Chan, Fitzgerald S Lao, et al.
Antiviral Research|April 20, 2006
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinDale L Barnard, Craig W Day, Kevin Bailey, et al.
The European Journal of Neuroscience|December 1, 2022
Medio-dorsal thalamic dysconnectivity in chronic knee pain: A possible mechanism for negative affect and pain comorbiditySarina J Iwabuchi, Marianne M Drabek, William J Cottam, et al.
Bioorganic & Medicinal Chemistry Letters|October 8, 2014
Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligandsAfshin Nour, Tomoko Hayashi, Michael Chan, et al.
Oncotarget|September 8, 2016
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapyMarka R Crittenden, Jason Baird, David Friedman, et al.
Cancer Research|July 19, 2002
Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of actionEmmanuel A Ojo-Amaize, Emeka J Nchekwube, Howard B Cottam, et al.
Pageof 57